Reduction of experimental ocular axial elongation by neuregulin-1 antibody

Background: Since the mechanisms underlying myopic axial elongation have remained unclear, we examined the effect of neuregulin-1 (NRG-1), an epidermal growth factor family member, on myopic axial elongation. Methods: The guinea pigs aged two to three weeks were subjected to bilateral negative lens-...

Full description

Saved in:
Bibliographic Details
Main Authors: Shi, Xu Han (Author) , Dong, Li (Author) , Zhang, Rui Heng (Author) , Zhou, Wen Da (Author) , Li, Yi Fan (Author) , Wu, Hao Tian (Author) , Li, He Yan (Author) , Yu, Chu Yao (Author) , Li, Yi Tong (Author) , Wang, Ya Xing (Author) , Jonas, Jost B. (Author) , Wei, Wen Bin (Author)
Format: Article (Journal)
Language:English
Published: 26 October 2023
In: Frontiers in medicine
Year: 2023, Volume: 10, Pages: 1-13
ISSN:2296-858X
DOI:10.3389/fmed.2023.1277180
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fmed.2023.1277180
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1277180/full
Get full text
Author Notes:Xu Han Shi, Li Dong, Rui Heng Zhang, Wen Da Zhou, Yi Fan Li, Hao Tian Wu, He Yan Li, Chu Yao Yu, Yi Tong Li, Ya Xing Wang, Jost B. Jonas, Wen Bin Wei

MARC

LEADER 00000caa a2200000 c 4500
001 1904185002
003 DE-627
005 20241205175414.0
007 cr uuu---uuuuu
008 241002s2023 xx |||||o 00| ||eng c
024 7 |a 10.3389/fmed.2023.1277180  |2 doi 
035 |a (DE-627)1904185002 
035 |a (DE-599)KXP1904185002 
035 |a (OCoLC)1475313683 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Shi, Xu Han  |e VerfasserIn  |0 (DE-588)1343798892  |0 (DE-627)1904185797  |4 aut 
245 1 0 |a Reduction of experimental ocular axial elongation by neuregulin-1 antibody  |c Xu Han Shi, Li Dong, Rui Heng Zhang, Wen Da Zhou, Yi Fan Li, Hao Tian Wu, He Yan Li, Chu Yao Yu, Yi Tong Li, Ya Xing Wang, Jost B. Jonas, Wen Bin Wei 
264 1 |c 26 October 2023 
300 |b Illustrationen 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.10.2024 
520 |a Background: Since the mechanisms underlying myopic axial elongation have remained unclear, we examined the effect of neuregulin-1 (NRG-1), an epidermal growth factor family member, on myopic axial elongation. Methods: The guinea pigs aged two to three weeks were subjected to bilateral negative lens-induced axial elongation and received weekly intravitreal injections into their right eyes of NRG-1 antibody (doses: 5 μg, n = 8; 10 μg, n = 8, 20 μg, n = 9) or of NRG-1 (doses: 0.05 μg, n = 8; 0.01 μg, n = 9; 0.2 μg, n = 8), underwent only bilateral negative lens-induced axial elongation (myopia control group, n = 10), or underwent no intervention (control group, n = 10). The contralateral eyes received corresponding intravitreal phosphate-buffered solution injections. One week after the last injection, the guinea pigs were sacrificed, the eyeballs were removed, the thicknesses of the retina and sclera were histologically examined, the expression of NRG-1 and downstream signal transduction pathway members (ERK1/2 and PI3K/AKT) and the mRNA expression of NRG-1 in the retina was assessed. Results: The inter-eye difference in axial length at study end increased (p 0.001) from the normal control group (−0.02 ± 0.09 mm) and the myopia control group (−0.01 ± 0.09 mm) to the low-dose NRG-1 antibody group (−0.11 ± 0.05 mm), medium-dose NRG-1 antibody group (−0.17 ± 0.07 mm), and high-dose NRG-1 antibody group (−0.28 ± 0.06 mm). The relative expression of NRG-1, ERK1/2, and PI3K/AKT in the retina decreased in a dose-dependent manner from the myopia control group to the NRG-1 antibody groups and the normal control group. The relative NRG-1 mRNA expression in the retina was higher (p 0.01) in the myopic control group than in the NRG-1 antibody groups and normal control group. Scleral and retinal thickness decreased from the normal control group to the NRG-1 antibody groups to the myopic control group. After intraocular injection of NRG-1 protein, there was a slight dose-dependent increase in the difference in axial length between the right and left eye, however not statistically significantly, from the normal control group (−0.02 ± 0.09 mm) to the high-dose NRG-1 protein group (0.03 ± 0.03 mm; p = 0.12). Conclusion: Intravitreal NRG-1 antibody application was dose-dependently and time-dependently associated with a reduction in negative lens-induced axial elongation in young guinea pigs. 
650 4 |a Axial elongation 
650 4 |a Axial elongation Neuregulin-1 
650 4 |a EGF 
650 4 |a Epidermal Growth Factor 
650 4 |a Myopia 
650 4 |a Neuregulin-1 
700 1 |a Dong, Li  |e VerfasserIn  |4 aut 
700 1 |a Zhang, Rui Heng  |e VerfasserIn  |4 aut 
700 1 |a Zhou, Wen Da  |e VerfasserIn  |4 aut 
700 1 |a Li, Yi Fan  |e VerfasserIn  |4 aut 
700 1 |a Wu, Hao Tian  |e VerfasserIn  |4 aut 
700 1 |a Li, He Yan  |e VerfasserIn  |4 aut 
700 1 |a Yu, Chu Yao  |e VerfasserIn  |4 aut 
700 1 |a Li, Yi Tong  |e VerfasserIn  |4 aut 
700 1 |a Wang, Ya Xing  |e VerfasserIn  |4 aut 
700 1 |a Jonas, Jost B.  |d 1958-  |e VerfasserIn  |0 (DE-588)1028286732  |0 (DE-627)730536823  |0 (DE-576)37578537X  |4 aut 
700 1 |a Wei, Wen Bin  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in medicine  |d Lausanne : Frontiers Media, 2014  |g 10(2023), Seite 1-13  |h Online-Ressource  |w (DE-627)789482991  |w (DE-600)2775999-4  |w (DE-576)408729597  |x 2296-858X  |7 nnas  |a Reduction of experimental ocular axial elongation by neuregulin-1 antibody 
773 1 8 |g volume:10  |g year:2023  |g pages:1-13  |g extent:13  |a Reduction of experimental ocular axial elongation by neuregulin-1 antibody 
856 4 0 |u https://doi.org/10.3389/fmed.2023.1277180  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1277180/full  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241002 
993 |a Article 
994 |a 2023 
998 |g 1028286732  |a Jonas, Jost B.  |m 1028286732:Jonas, Jost B.  |d 60000  |e 60000PJ1028286732  |k 0/60000/  |p 12  |y j 
999 |a KXP-PPN1904185002  |e 4586120363 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Shi, Xu Han","family":"Shi","given":"Xu Han","role":"aut"},{"role":"aut","given":"Li","display":"Dong, Li","family":"Dong"},{"role":"aut","given":"Rui Heng","display":"Zhang, Rui Heng","family":"Zhang"},{"given":"Wen Da","role":"aut","display":"Zhou, Wen Da","family":"Zhou"},{"role":"aut","given":"Yi Fan","display":"Li, Yi Fan","family":"Li"},{"given":"Hao Tian","role":"aut","display":"Wu, Hao Tian","family":"Wu"},{"given":"He Yan","role":"aut","display":"Li, He Yan","family":"Li"},{"family":"Yu","display":"Yu, Chu Yao","role":"aut","given":"Chu Yao"},{"given":"Yi Tong","role":"aut","family":"Li","display":"Li, Yi Tong"},{"family":"Wang","display":"Wang, Ya Xing","given":"Ya Xing","role":"aut"},{"display":"Jonas, Jost B.","family":"Jonas","role":"aut","given":"Jost B."},{"display":"Wei, Wen Bin","family":"Wei","role":"aut","given":"Wen Bin"}],"language":["eng"],"origin":[{"dateIssuedDisp":"26 October 2023","dateIssuedKey":"2023"}],"note":["Gesehen am 02.10.2024"],"title":[{"title":"Reduction of experimental ocular axial elongation by neuregulin-1 antibody","title_sort":"Reduction of experimental ocular axial elongation by neuregulin-1 antibody"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1904185002","relHost":[{"language":["eng"],"part":{"pages":"1-13","year":"2023","volume":"10","text":"10(2023), Seite 1-13","extent":"13"},"titleAlt":[{"title":"FMED"},{"title":"Front. Med."}],"recId":"789482991","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2775999-4"],"issn":["2296-858X"],"eki":["789482991"]},"origin":[{"dateIssuedDisp":"2014-","publisher":"Frontiers Media","dateIssuedKey":"2014","publisherPlace":"Lausanne"}],"note":["Gesehen am 09.02.2021"],"pubHistory":["2014 -"],"title":[{"title_sort":"Frontiers in medicine","title":"Frontiers in medicine"}],"disp":"Reduction of experimental ocular axial elongation by neuregulin-1 antibodyFrontiers in medicine","type":{"media":"Online-Ressource","bibl":"periodical"}}],"name":{"displayForm":["Xu Han Shi, Li Dong, Rui Heng Zhang, Wen Da Zhou, Yi Fan Li, Hao Tian Wu, He Yan Li, Chu Yao Yu, Yi Tong Li, Ya Xing Wang, Jost B. Jonas, Wen Bin Wei"]},"physDesc":[{"extent":"13 S.","noteIll":"Illustrationen"}],"id":{"doi":["10.3389/fmed.2023.1277180"],"eki":["1904185002"]}} 
SRT |a SHIXUHANDOREDUCTIONO2620